1. AIFA, Agenzia Italiana del Farmaco, “Farmaci in gravidanza”, 2005.
2. Entman S.S., Moise K.J., S. Med. J., 1984, 77, 402.
3. Ewan P.W., Clark A.T., Lancet, 2001, 357, 111.
4. Gotz V.P. et al., Ann. Emerg.Med., 1981, 10, 518.
5. Hannaway P.J., Hopper G.D.K., NEJM,1983, 302, 1536.
6. Hourihane J. O’B. et al., Arch. Di. Child., 2002, 87, 450.
7. Keating G. et al., BMJ, 1984, 289, 348.
8. Lieberman P., J. Allergy Clin. Immunol., 1990, 86, 684.
9. Nishimura H., Tanimra T., Excepta Medica, American Elsevier Publishing Co, New York, 1976.
10. Perry S.M., Kambam J.R., JAMA ed. It., 1990, 2, 268.
11. Rodrigo G.J., Nannini L.J., Am. J. Emerg. Med., 2006, 24 (2), 217.
12. Simons F.E.R., Gu X., J. Allergy Clin. Immunol., 2001, 108, 871.
13. The World Anti-Doping Code International Standard, Prohibited list, 2019, January https://www.wada-ama.org/sites/default/files/wada_2019_english_prohibited_list.pdf
14. Warren J.B. et al., Clin. Pharmacol. Ther., 1986, 40, 673.
Link
New England Journal of Medicine
www.content.nejm.org
1) “Epinephrine and Dexamethasone in Children with Bronchiolitis”, NEJM, 2009, 360, 2079.